CMS’s Current and Proposed Actions to Bend the Prescription Drug Cost Curve

CMS's current and proposed actions to address the rising cost of drugs employ both offensive and defensive tactics; which ones are making the biggest difference?

Employers and Benefits Consultants Assess Gene Therapy Costs and Solutions

Employer concerns are increasing in response to the rising number of "seven-figure costs" associated with emerging gene therapies. What does the future hold for employer coverage of advanced therapies?